Cubit Lifesciences is a finished-dose manufacturer based in India. It appears in 21 regulatory filings across 3 regulators, without an active US DMF or CEP on file. Its filings concentrate with ARCSA (EC), BOMRA (BW) and MINSA (CR). Its GMP standing is certified by CDSCO (India), FDA (GH) and TMDA (TZ), among 5 authorities. Customs aggregates show $878K of exports covering 119 molecules to 11 destinations in 2025.
| Site | FDA FEI |
|---|---|
| Bhayla, India | Not on file |
| tal bavlaahmedabad 382 220, India | Not on file |
| Regulator | Filings | GMP certificates |
|---|---|---|
| ARCSA (EC) | 14 | None |
| BOMRA (BW) | 5 | None |
| MINSA (CR) | 2 | None |
| CDSCO (India) | None | 2 |
| FDA (GH) | None | 1 |
| TMDA (TZ) | None | 1 |
| EMA | None | 1 |
| MCAZ (ZW) | None | 1 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2026 YTD | Not reported | $200K | 5 |
| 2025 | Not reported | $878K | 11 |
| 2024 | Not reported | $408K | 5 |
| 2023 | Not reported | $408K | 2 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Choose your molecules and target markets. Cubit Lifesciences comes back tiered against every other supplier able to file there.
Start for free